Large-scale testing (Phase 3)UnknownNCT04665986What this trial is testingNeoadjuvant Study of Navelbine in Patients With HER2 Positive Breast CancerWho this might be right forBreast Cancer Zhejiang Cancer Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT05180006What this trial is testingImpact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard TherapyWho this might be right forBreast Cancer Gustave Roussy, Cancer Campus, Grand Paris 33
Not applicableUnknownNCT03797248What this trial is testingProspective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast CancerWho this might be right forEarly-stage Breast Cancer Chang Gung Memorial Hospital 310
Not applicableStudy completedNCT04491578What this trial is testingAn Advance Care Planning Programme for Persons With Early Stage Dementia in the CommunityWho this might be right forDementia MildMild Cognitive Impairment Hong Kong Metropolitan University 100
Not applicableWithdrawnNCT00084578What this trial is testingCelecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWho this might be right forBladder Cancer Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00698035What this trial is testingVaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer PatientsWho this might be right forSexual Dysfunction, Physiological University of California, San Francisco 76
Not applicableLooking for participantsNCT06279026What this trial is testingUTAA17 Injection in the Treatment of Relapsed/Refractory Multiple MyelomaWho this might be right forRelapsed/Refractory Multiple Myeloma PersonGen BioTherapeutics (Suzhou) Co., Ltd. 15
Testing effectiveness (Phase 2)Looking for participantsNCT04891068What this trial is testingBRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast CancerWho this might be right forBreast Cancer InvasiveEarly-stage Breast CancerHigh Risk Breast Carcinoma University of Illinois at Chicago 40
Not applicableStudy completedNCT01078415What this trial is testingPilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)Who this might be right forCarcinoma, Hepatocellular Angiodynamics, Inc. 26
Not applicableStudy completedNCT06536140What this trial is testingThe Lived Experiences of Persons With Early Stage Non-small Cell Lung Cancer and Their Significant Other(s) Following Surgery: a Rapid Ethnographic ApproachWho this might be right forLung Cancer Hasselt University 16
Testing effectiveness (Phase 2)UnknownNCT05914662What this trial is testingZanubrutinib Plus BR in Newly Diagnosed Symptomatic WMWho this might be right forWaldenstrom Macroglobulinemia Institute of Hematology & Blood Diseases Hospital, China 42
Very early researchStudy completedNCT01434342What this trial is testingFeasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer PatientsWho this might be right forLung CancerTobacco Use DisorderBreast Cancer+2 more Wake Forest University Health Sciences 146
Not applicableUnknownNCT01157962What this trial is testingSentinel Concept in Early Stage Cervical CancerWho this might be right forCervical Cancer Charite University, Berlin, Germany 1,600
Early research (Phase 1)Study completedNCT02603003What this trial is testingThe"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCsWho this might be right forNon-small Cell Lung Cancer(NSCLC) Shanghai University of Traditional Chinese Medicine 218
Not applicableLooking for participantsNCT06781281What this trial is testingNabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.Who this might be right forBreast Cancer Invasive Henan Cancer Hospital 709
Testing effectiveness (Phase 2)Ended earlyNCT03968419What this trial is testingThis Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.Who this might be right forNon-small Cell Lung Cancer Novartis Pharmaceuticals 88
Testing effectiveness (Phase 2)WithdrawnNCT04648189What this trial is testingCetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLCWho this might be right forLung CancerSurgeryCirculating Tumor Cell The Netherlands Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT07371650What this trial is testingThis is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaWho this might be right forInfluenza Traws Pharma, Inc. 105
Not applicableLooking for participantsNCT05974475What this trial is testingMONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung CancerWho this might be right forLung Neoplasm Malignant European Institute of Oncology 270
Early research (Phase 1)Not Yet RecruitingNCT07169565What this trial is testingIbrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström MacroglobulinemiaWho this might be right forWaldenström Macroglobulinemia (WM) Institute of Hematology & Blood Diseases Hospital, China 21